BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27698500)

  • 1. Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL).
    Damery E; Solimando DA; Waddell JA
    Hosp Pharm; 2016 Sep; 51(8):628-632. PubMed ID: 27698500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gefitinib and Sonidegib.
    Medler CJ; Waddell JA; Solimando DA
    Hosp Pharm; 2015 Nov; 50(10):868-872. PubMed ID: 27729673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dinutuximab and Panobinostat.
    Chasick A; Solimando DA; Waddell JA
    Hosp Pharm; 2015 Oct; 50(9):767-72. PubMed ID: 26912916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blinatumomab and Pembrolizumab.
    Tabor EE; Waddell JA; Solimando DA
    Hosp Pharm; 2015 Apr; 50(4):269-73. PubMed ID: 26448656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzalutamide and ruxolitinib.
    Hobson SA; Waddell JA; Solimando DA
    Hosp Pharm; 2013 Feb; 48(2):104-7. PubMed ID: 24421446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lenvatinib and Palbociclib.
    Solimando DA; Waddell JA
    Hosp Pharm; 2015 Jul; 50(7):578-82. PubMed ID: 26448668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nivolumab and Olaparib.
    Solimando DA; Waddell JA
    Hosp Pharm; 2015 May; 50(5):356-66. PubMed ID: 26405320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clofarabine and Cytarabine Regimen for Acute Myeloid Leukemia.
    Ho KV; Solimando DA; Waddell JA
    Hosp Pharm; 2015 Nov; 50(11):969-74. PubMed ID: 27621503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel, Carboplatin, and trastuzumab.
    Lee J; Solimando DA; Waddell JA
    Hosp Pharm; 2014 Nov; 49(10):913-9. PubMed ID: 25477563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paclitaxel and trastuzumab for breast cancer.
    Lehmann T; Solimando DA; Waddell JA
    Hosp Pharm; 2014 Apr; 49(4):338-44. PubMed ID: 24958939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alectinib, Ceritinib, Elotuzumab, and Venetoclax.
    Waddell JA; Solimando DA
    Hosp Pharm; 2016 Jul; 51(7):524-34. PubMed ID: 27559185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug Monographs: Ixazomib and Necitumumab.
    Lawson FE; Waddell JA; Solimando DA
    Hosp Pharm; 2016 May; 51(5):362-6. PubMed ID: 27303088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug monographs: belinostat and idelalisib.
    Piper WL; Waddell JA; Solimando DA
    Hosp Pharm; 2014 Dec; 49(11):1009-13. PubMed ID: 25673888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug monographs: pomalidomide and ponatinib.
    Butler TW; Waddell JA; Solimando DA
    Hosp Pharm; 2013 Sep; 48(8):636-41. PubMed ID: 24421531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and Vinorelbine (GemVin) Regimen.
    Shang EY; Solimando DA; Waddell JA
    Hosp Pharm; 2014 Jun; 49(6):508-16. PubMed ID: 24958967
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug monographs: ibrutinib and ramucirumab.
    Solimando DA; Waddell JA
    Hosp Pharm; 2014 Sep; 49(8):702-9. PubMed ID: 25477594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug monographs: bosutinib and regorafenib.
    Solimando DA; Waddell JA
    Hosp Pharm; 2013 Mar; 48(3):190-4. PubMed ID: 24421459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug Monographs: Daratumumab and Osimertinib.
    Solimando DA; Waddell JA
    Hosp Pharm; 2016 Apr; 51(4):288-92. PubMed ID: 27303075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug monographs: dabrafenib and trametinib.
    Waddell JA; Solimando DA
    Hosp Pharm; 2013 Nov; 48(10):818-21. PubMed ID: 24421433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug Monographs: Avelumab and Ribociclib.
    Waddell JA; Solimando DA
    Hosp Pharm; 2017 Jul; 52(7):459-463. PubMed ID: 29276273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.